Skip to content

Inventories at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$14.58B+15.2%
AbbVie logo
AbbVieABBV
$5.05B+11.6%
Globus Medical logo
Globus MedicalGMED
$772.6M+16.4%
Solventum logo
SolventumSOLV
$1.09B+25.8%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$300.3M+14.9%
Stryker logo
StrykerSYK
$5.42B+6.2%

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's inventories?
Establishment Labs (ESTA) reported inventories of $86.66M in Q1 2026.
How has Establishment Labs's inventories changed year-over-year?
Establishment Labs's inventories decreased by 4.2% year-over-year, from $90.43M to $86.66M.
What is the long-term trend for Establishment Labs's inventories?
Over 5 years (2020 to 2025), Establishment Labs's inventories has grown at a 29.8% compound annual growth rate (CAGR), from $23.21M to $85.61M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.